On 19 May 2026, colleagues from VPH joined a public event in Milan hosted by EUPATI Italia and the IEO European Institute of Oncology to discuss the increasing importance of the role of patient in medical research and innovation.
A recent event at the European Parliament brought renewed attention to the growing role of NAMs highlighting the forthcoming European Biotech Act as a major opportunity to accelerate the transition toward non-animal science while strengthening Europe’s global competitiveness.
A newly FDA-cleared AI system marks a major milestone in the use of real-time artificial intelligence for early sepsis detection in hospitals. This article explores how continuous AI monitoring, machine learning, and personalised medicine could transform critical care while highlighting the scientific, clinical, and regulatory challenges that still remain
The call for applications for the new VPH Young Scientists Committee is now open! We are seeking motivated early-career researchers in in silico medicine who are eager to actively contribute to and shape the VPH community.
The call for nominations for the new Executive Committee is now open! We are seeking motivated and committed scientists to join the Committee and contribute to advancing the adoption of in silico medicine through leadership, collaboration, and community engagement.
The European Medicines Agency (EMA) has introduced a dedicated pilot procedure for scientific advice and protocol assistance on model-informed drug development (MIDD) — a significant step forward for the in silico community and a clear regulatory signal that quantitative modelling evidence is coming of age.
Our scientific officer, Janaki Raman, joined the global regulatory affairs community in Lisbon for RAPS Euro Convergence 2026 — and in silico medicine was firmly on the agenda.
The VPH Society will award up to six Travel Vouchers to support VPH student members attending the VPH 2026 Conference in Milan, covering travel, accommodation, and living expenses. Applications will be evaluated based on scientific merit, diversity, and inclusion criteria.
The VPH Best Presentation Award recognises the best oral presentation delivered by a VPH student member at the VPH 2026 Conference. The winner will receive a certificate and a €500 cash prize.
VPH – The Society for In Silico Medicine is a partner in the DT4PH project. On 10 June 2026, the project hosts a one-day event in Leuven bringing together clinicians, researchers, industry, regulators, and patients to explore how digital twins and AI can be responsibly implemented in personalised healthcare.
